178 related articles for article (PubMed ID: 34252346)
21. Identification of the shared hub gene signatures and molecular mechanisms between HIV-1 and pulmonary arterial hypertension.
Mai H; Yang X; Xie Y; Zhou J; Wei Y; Luo T; Yang J; Cui P; Ye L; Liang H; Huang J
Sci Rep; 2024 Mar; 14(1):7048. PubMed ID: 38528047
[TBL] [Abstract][Full Text] [Related]
22. Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension.
Lin W; Tang Y; Zhang M; Liang B; Wang M; Zha L; Yu Z
Front Med (Lausanne); 2022; 9():894584. PubMed ID: 35646965
[TBL] [Abstract][Full Text] [Related]
23. Transcriptomic analysis identifies Toll-like and Nod-like pathways and necroptosis in pulmonary arterial hypertension.
Xiao G; Zhuang W; Wang T; Lian G; Luo L; Ye C; Wang H; Xie L
J Cell Mol Med; 2020 Oct; 24(19):11409-11421. PubMed ID: 32860486
[TBL] [Abstract][Full Text] [Related]
24. FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension.
Qu LH; Luo WJ; Yan ZG; Liu WP
Mediators Inflamm; 2022; 2022():1878766. PubMed ID: 36248192
[TBL] [Abstract][Full Text] [Related]
25. Identification of Potential Biomarkers and Immune Infiltration Characteristics in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Analysis.
Zeng H; Liu X; Zhang Y
Front Cardiovasc Med; 2021; 8():624714. PubMed ID: 33598484
[No Abstract] [Full Text] [Related]
26. Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis.
Wei RQ; Zhang WM; Liang Z; Piao C; Zhu G
Can Respir J; 2022; 2022():1394088. PubMed ID: 36072642
[TBL] [Abstract][Full Text] [Related]
27. Identification of Crucial Hub Genes and Differential T Cell Infiltration in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Strategies.
Yang X; Wang C; Lin Y; Zhang P
Front Mol Biosci; 2022; 9():800888. PubMed ID: 35127829
[No Abstract] [Full Text] [Related]
28. Identification of novel biomarkers involved in pulmonary arterial hypertension based on multiple-microarray analysis.
Ma Y; Chen SS; Feng YY; Wang HL
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32886110
[TBL] [Abstract][Full Text] [Related]
29. Exploration of the Shared Gene Signatures and Molecular Mechanisms Between Systemic Lupus Erythematosus and Pulmonary Arterial Hypertension: Evidence From Transcriptome Data.
Yao M; Zhang C; Gao C; Wang Q; Dai M; Yue R; Sun W; Liang W; Zheng Z
Front Immunol; 2021; 12():658341. PubMed ID: 34335565
[TBL] [Abstract][Full Text] [Related]
30. Integrated Bioinformatics Analysis Reveals Marker Genes and Potential Therapeutic Targets for Pulmonary Arterial Hypertension.
Li A; He J; Zhang Z; Jiang S; Gao Y; Pan Y; Wang H; Zhuang L
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573320
[TBL] [Abstract][Full Text] [Related]
31. Identification of
Gong Q; Hu Z; Jin Q; Yan Y; Liu Y; He J; Zhuang L; Wang H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555200
[TBL] [Abstract][Full Text] [Related]
32. Identification of key candidate genes and biological pathways in neuropathic pain.
Cui CY; Liu X; Peng MH; Liu Q; Zhang Y
Comput Biol Med; 2022 Nov; 150():106135. PubMed ID: 36166989
[TBL] [Abstract][Full Text] [Related]
33. Identifying Potential Mitochondrial Proteome Signatures Associated with the Pathogenesis of Pulmonary Arterial Hypertension in the Rat Model.
Wang J; Uddin MN; Li Q; Aierken A; Li MY; Wang R; Yan QZ; Adi D; Gai MT; Wu Y
Oxid Med Cell Longev; 2022; 2022():8401924. PubMed ID: 35237384
[TBL] [Abstract][Full Text] [Related]
34. Potential mechanisms and serum biomarkers involved in sex differences in pulmonary arterial hypertension.
Li C; Zhang Z; Xu Q; Wu T; Shi R
Medicine (Baltimore); 2020 Mar; 99(13):e19612. PubMed ID: 32221085
[TBL] [Abstract][Full Text] [Related]
35. Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension.
Jiang CY; Wu LW; Liu YW; Feng B; Ye LC; Huang X; He YY; Shen Y; Zhu YF; Zhou XL; Jiang DJ; Qi HK; Zhang H; Yan Y
Front Immunol; 2023; 14():1153573. PubMed ID: 37449198
[TBL] [Abstract][Full Text] [Related]
36. Novel insights into the molecular mechanisms underlying the beneficial effects of exercise training on pulmonary arterial hypertension.
Su Y; Wang J; Quan M
J Sports Med Phys Fitness; 2019 Sep; 59(9):1584-1592. PubMed ID: 30421875
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatic analysis of hub markers and immune cell infiltration characteristics of gastric cancer.
Li C; Yang T; Yuan Y; Wen R; Yu H
Front Immunol; 2023; 14():1202529. PubMed ID: 37359529
[TBL] [Abstract][Full Text] [Related]
38. RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension.
Lu G; Du R; Liu Y; Zhang S; Li J; Pei J
Vasc Health Risk Manag; 2023; 19():673-688. PubMed ID: 37881333
[TBL] [Abstract][Full Text] [Related]
39. Identification of hub biomarkers of myocardial infarction by single-cell sequencing, bioinformatics, and machine learning.
Zhang Q; Guo Y; Zhang B; Liu H; Peng Y; Wang D; Zhang D
Front Cardiovasc Med; 2022; 9():939972. PubMed ID: 35958412
[TBL] [Abstract][Full Text] [Related]
40. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
Wan Z; Zhang X; Luo Y; Zhao B
Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
